NCT00408382
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Osaka, Japan
- Tokyo, Japan
Clinical trial condition
Myocardial Ischemia
Explore clinical trials studying Myocardial Ischemia. Study availability and eligibility vary by location and protocol.
6,490 public trials
898 recruiting studies
Myocardial Ischemia trial results
Completed
Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty
NCT00354406
- Conditions
- Cardiovascular Diseases, Heart Diseases, Infarction, +7 more
- Locations
-
- Cardiothoracic Department, Ospedale Cisanello Pisa, Italy
Completed
ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation
NCT01184300
- Conditions
- Acute Coronary Syndrome, Cardiovascular Diseases, Heart Diseases, +4 more
- Locations
-
- University of Ottawa Heart Institute Ottawa, Ontario, Canada
NCT01466634
- Conditions
- Cardiovascular Diseases, Heart Diseases, Infarction, +8 more
- Locations
-
- Ospedale Maggiore della Carità Novara, Italy
NCT00067236
- Conditions
- Cardiomegaly, Cardiovascular Diseases, Heart Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences and Central Arkansas Veterans Health Care System Little Rock, Arkansas, United States
- Mercy Community Medical Center Merced, California, United States
- Porter Adventist Hospital Denver, Colorado, United States
- University of Connecticut Health Center Farmington, Connecticut, United States
NCT00830960
- Conditions
- Acute Coronary Syndrome, Cardiovascular Diseases, Heart Diseases, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China
NCT00581399
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
- Locations
-
- University of California, Irvine Medical Center Orange, California, United States
Completed
Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis
NCT00940862
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Montreal Heart Institute Montreal, Quebec, Canada
- Innovaderm Research Inc Montreal, Quebec, Canada
NCT00597324
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
- Locations
-
- University Hospital Ferrara, FE, Italy
Completed
Heparin's Influence on ROTEM® Analysis
NCT01455454
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
- Locations
-
- University of Lausanne Hospitals Lausanne, Canton of Vaud, Switzerland